1. US Congress. 21st Century Cures Act. HR 34, 114th Congress, enacted on Dec 13, 2016.
2. Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, et al. Real-world evidence—what is it and what can it tell us? N Engl J Med. 2016;375(23):2293–7. https://doi.org/10.1056/NEJMsb1609216.
3. Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act, Pediatric Research Equity Act, Board on Health Sciences Policy, Institute of Medicine. In: Field MJ, Boat TF, editors. Safe and effective medicines for children: pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Washington, DC: National Academies Press; 2012.
4. Frattarelli DA, Galinkin JL, Green TP, Johnson TD, Neville KA, Paul IM, et al. Off-label use of drugs in children. Pediatrics. 2014;133(3):563–7. https://doi.org/10.1542/peds.2013-4060.
5. Joseph PD, Craig JC, Caldwell PHY. Clinical trials in children. Br J Clin Pharmacol. 2015;79(3):357–69. https://doi.org/10.1111/bcp.12305.